JP2002517185A5 - - Google Patents

Download PDF

Info

Publication number
JP2002517185A5
JP2002517185A5 JP2000552152A JP2000552152A JP2002517185A5 JP 2002517185 A5 JP2002517185 A5 JP 2002517185A5 JP 2000552152 A JP2000552152 A JP 2000552152A JP 2000552152 A JP2000552152 A JP 2000552152A JP 2002517185 A5 JP2002517185 A5 JP 2002517185A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000552152A
Other languages
Japanese (ja)
Other versions
JP2002517185A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/012253 external-priority patent/WO1999062942A2/en
Publication of JP2002517185A publication Critical patent/JP2002517185A/ja
Publication of JP2002517185A5 publication Critical patent/JP2002517185A5/ja
Withdrawn legal-status Critical Current

Links

JP2000552152A 1998-06-01 1999-06-01 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原 Withdrawn JP2002517185A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8759898P 1998-06-01 1998-06-01
US60/087,598 1998-06-01
US9147498P 1998-06-29 1998-06-29
US60/091,474 1998-06-29
US12952199P 1999-04-14 1999-04-14
US60/129,521 1999-04-14
PCT/US1999/012253 WO1999062942A2 (en) 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008330218A Division JP2009148265A (ja) 1998-06-01 2008-12-25 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原

Publications (2)

Publication Number Publication Date
JP2002517185A JP2002517185A (ja) 2002-06-18
JP2002517185A5 true JP2002517185A5 (US07585860-20090908-C00136.png) 2005-12-22

Family

ID=27375711

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000552152A Withdrawn JP2002517185A (ja) 1998-06-01 1999-06-01 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原
JP2008330218A Pending JP2009148265A (ja) 1998-06-01 2008-12-25 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008330218A Pending JP2009148265A (ja) 1998-06-01 2008-12-25 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原

Country Status (12)

Country Link
US (1) US20060275304A1 (US07585860-20090908-C00136.png)
EP (1) EP1082341B1 (US07585860-20090908-C00136.png)
JP (2) JP2002517185A (US07585860-20090908-C00136.png)
AT (1) ATE490977T1 (US07585860-20090908-C00136.png)
AU (2) AU773187B2 (US07585860-20090908-C00136.png)
CA (1) CA2329137C (US07585860-20090908-C00136.png)
CY (1) CY1111906T1 (US07585860-20090908-C00136.png)
DE (1) DE69943020D1 (US07585860-20090908-C00136.png)
DK (1) DK1082341T3 (US07585860-20090908-C00136.png)
IL (1) IL139988A0 (US07585860-20090908-C00136.png)
PT (1) PT1082341E (US07585860-20090908-C00136.png)
WO (1) WO1999062942A2 (US07585860-20090908-C00136.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) * 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
CA2344552A1 (en) * 1998-10-02 2000-04-13 Urogenesys, Inc. Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000023111A1 (en) * 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000065067A2 (en) * 1999-04-23 2000-11-02 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
PT1200590E (pt) 1999-08-12 2009-03-24 Agensys Inc Antigénio transmembranar lectina tipo c expresso em cancro da próstata humano e utilizações do mesmo
CA2411278A1 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
ES2305093T3 (es) 2000-06-13 2008-11-01 Bayer Healthcare Ag Regulacion de la serina proteasa transmembrana humana.
AU2002218786A1 (en) * 2000-07-12 2002-01-21 Agensys, Inc. Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
US6743592B1 (en) * 2000-07-25 2004-06-01 The Trustees Of The University Of Pennsylvania Methods, systems and kits for immuno-detection of epitopes expressed on molecules
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
WO2004092397A2 (en) * 2003-04-15 2004-10-28 Novartis Ag Tmprss2 regulatory sequences and uses thereof
WO2004097358A2 (en) * 2003-05-02 2004-11-11 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2)
CA2622295C (en) 2005-09-12 2019-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
WO2008119767A2 (en) * 2007-03-30 2008-10-09 Oryzon Genomics, S. A. Method of nucleic acid analysis.
CA2692793C (en) 2007-07-06 2014-05-20 The Regents Of The University Of Michigan Mipol1-etv1 gene rearrangements
WO2009020521A2 (en) 2007-08-03 2009-02-12 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
JP5800817B2 (ja) 2009-09-17 2015-10-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌における再発性遺伝子融合
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
MX360352B (es) * 2012-02-15 2018-10-30 Hoffmann La Roche Cromatografia de afinidad basada en receptores fc.
PL3215528T3 (pl) 2014-11-06 2020-01-31 F.Hoffmann-La Roche Ag Warianty regionu Fc ze zmodyfikowanym wiązaniem FcRn i sposoby stosowania

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク,インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5288612A (en) * 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
ATE242330T1 (de) * 1993-01-15 2003-06-15 Inst Genetics Llc Klonierung von enterokinase und verfahren zu deren verwendung
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6657056B2 (en) * 1997-02-25 2003-12-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
CO4870792A1 (es) * 1997-02-25 1999-12-27 Corixa Corp Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
HUP0002095A3 (en) * 1997-02-25 2002-02-28 Corixa Corp Seattle Compounds for immunotherapy of prostate cancer and methods for their use
US20030103981A1 (en) * 1997-02-27 2003-06-05 Incyte Genomics, Inc. Methods of use of a prostate-associated protease in the diagnosis and treatment of prostate cancer
US20020119531A1 (en) * 1997-02-27 2002-08-29 Olga Bandman Prostate-associated protease antibody
US6043033A (en) * 1997-02-27 2000-03-28 Incyte Pharmaceuticals, Inc. Human prostate-associated protease
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
AU4839999A (en) * 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
US6331427B1 (en) * 1999-03-26 2001-12-18 Millennium Pharmaceuticals, Inc. Protease homologs
US20020192763A1 (en) * 2000-04-17 2002-12-19 Jiangchun Xu Compositions and methods for the therapy and diagnosis of prostate cancer
US20020160382A1 (en) * 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer

Similar Documents

Publication Publication Date Title
BE2018C020I2 (US07585860-20090908-C00136.png)
BE2015C057I2 (US07585860-20090908-C00136.png)
BE2016C007I2 (US07585860-20090908-C00136.png)
BE2015C018I2 (US07585860-20090908-C00136.png)
BE2014C017I2 (US07585860-20090908-C00136.png)
BE2013C015I2 (US07585860-20090908-C00136.png)
BE2013C001I2 (US07585860-20090908-C00136.png)
BE2012C036I2 (US07585860-20090908-C00136.png)
BE2011C004I2 (US07585860-20090908-C00136.png)
BE2010C011I2 (US07585860-20090908-C00136.png)
BE2008C046I2 (US07585860-20090908-C00136.png)
BE1025464I2 (US07585860-20090908-C00136.png)
JP2002519753A5 (US07585860-20090908-C00136.png)
BRPI0017527B8 (US07585860-20090908-C00136.png)
JP2002502653A5 (US07585860-20090908-C00136.png)
JP2002514834A5 (US07585860-20090908-C00136.png)
JP2002508601A5 (US07585860-20090908-C00136.png)
BE2008C047I2 (US07585860-20090908-C00136.png)
BRPI0001672A2 (US07585860-20090908-C00136.png)
BRPI0001542A2 (US07585860-20090908-C00136.png)
JP2002501359A5 (US07585860-20090908-C00136.png)
JP2002517185A5 (US07585860-20090908-C00136.png)
JP2002518607A5 (US07585860-20090908-C00136.png)
JP2002507043A5 (US07585860-20090908-C00136.png)
JP2002511359A5 (US07585860-20090908-C00136.png)